Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
113,330
-
Share change
-
+71,210
-
Total reported value
-
$131,709
-
Price per share
-
$1.16
-
Number of holders
-
17
-
Value change
-
+$73,145
-
Number of buys
-
8
-
Number of sells
-
4
Institutional Holders of Alzamend Neuro, Inc. - COM NEW (ALZN) as of Q4 2024
As of 31 Dec 2024,
Alzamend Neuro, Inc. - COM NEW (ALZN) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
113,330 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, TRUIST FINANCIAL CORP, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, BlackRock, Inc., UBS Group AG, CITIGROUP INC, Tower Research Capital LLC (TRC), and BANK OF AMERICA CORP /DE/.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.